Masami Tsukabe

Clinicopathological Analysis of Breast Ductal Carcinoma in situ with ALDH1-Positive Cancer Stem Cells

S. Noguchi, Seung Jin Kim, M. Shimoda, 2013, Oncology.

Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer

H. Iwata, J. Watanabe, N. Masuda, 2017, Breast Cancer Research and Treatment.

Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316)

N. Masuda, Y. Tokumaru, M. Futamura, 2023, Breast Cancer.

High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer

S. Seno, T. Tanei, M. Shimoda, 2024, Cancers.